Perrigo Rx Divestment Remains ‘On Track’
As Business Buffeted By COVID And Albuterol Woes
Perrigo says its deal to divest its Rx business remains “on track,” with the company shunting the prescription unit into “discontinued operations” in the first quarter as it trains its focus on the firm’s future growth engine of consumer self-care.
